CHRN ChronoScale Holdings Corp

CHRN financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1549084 Exchange: Nasdaq SIC: 3569 (General Industrial Machinery & Equipment, NEC) Latest filing: 10-Q filed Oct 14, 2026 Data checked: Oct 21, 2026
Showing 3 of 15 annual and 0 of 55 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$15.55M (Nov 2025)
Industry (SIC)
3569 General Industrial Machinery & Equipment, NEC
Incorporated
NV
Fiscal Year End
May (0531)
Phone
(650) 977-4969
EIN
423357005
Headquarters
MENLO PARK, CA, 94025
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: ChronoScale Corp (2026–2026) · EKSO BIONICS HOLDINGS, INC. (2014–2026) · PN Med Group Inc (2012–2013)

▼ Key Metrics (TTM)

As of Mar 31, 2026
Financials
Revenue
$11.57M
Net Income
$-15.69M
Total Assets
$19.67M
Total Equity
$2.09M
Total Debt
-
Free Cash Flow
$-12.14M
Ratios
Gross Margin
52.9%
Operating Margin
-134.1%
Net Margin
-135.7%
Return on Equity
-750.7%
Return on Assets
-79.8%
Current Ratio
1.55x
FCF / Assets
-61.7%

▼ FY 2026 Summary Analysis

Annual report ending May 31, 2026

Overview and Growth

In fiscal 2026, ChronoScale Holdings Corp recorded $71.60M of revenue, net loss of $50.32M, and an operating cash inflow of $39.07M. At $71.60M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 459.4% above fiscal 2025 revenue of $12.80M, marking a year-over-year increase. Diluted earnings per share were -$0.36, translating the period’s attributable earnings into the amount reported for each diluted share. The company employed $325.87M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.22x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Direct costs exceeded revenue, producing a gross loss of $17.09M before operating expenses. The gross loss equaled 23.9% of revenue, quantifying the direct-cost deficit before operating expenses. The reported operating result was an operating loss of $37.50M, reflecting costs that exceeded gross profit. Relative to revenue, the operating deficit measured 52.4%, showing the shortfall after operating costs. The company ended the period with a net loss of $50.32M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 70.3% after all recognized items. The pretax result was a loss of $49.30M, establishing the deficit before tax effects. The pretax loss equaled 68.9% of revenue, measuring the pre-tax deficit against sales. Income tax expense totaled $0.00, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-equity relationship was 28.0%, placing the bottom-line deficit against shareholder capital. Relative to total assets, the net loss represented 15.4%. The bottom-line deficit increased from $11.70M in fiscal 2025 to $50.32M.

Liquidity and Capital Structure

The company held $325.87M of assets against $143.84M of liabilities and $180.03M of equity, revealing how the asset base was financed. At period end, current assets of $44.25M compared with current liabilities of $86.89M, defining the company’s short-term resource position. The current ratio was 0.51x; current liabilities exceeded current assets, leaving a short-term liquidity deficit. The company held $9.66M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 11.1% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $3.84M, establishing the amount of borrowing carried within the company’s capital structure. Against book equity, debt measured 0.02x, placing the company’s financial leverage in clear balance-sheet terms. Relative to total assets, debt measured 1.2%, showing how much of the asset base was matched by borrowing. The equity-to-assets relationship was 55.2%, placing book capital against the total resource base. Relative to total assets, liabilities measured 44.1%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 3.0%, a balance-sheet composition measure rather than a liquidity forecast. Cash and equivalents were 726.7% higher than fiscal 2025 cash of $1.17M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

The company reported $39.07M of operating cash flow, a cash inflow that shows the cash generated by operations. The cash-flow statement records $26.88M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 68.8% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $12.19M, leaving cash available for debt reduction, shareholder returns, or further investment. The free-cash-flow margin was 17.0%, measuring cash remaining after capital spending against revenue. Free cash flow equaled 3.7% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending May 31, 2026. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for ChronoScale Holdings Corp
Metric FY2026 📄 FY2025 📄 FY2024 📄
Income Statement
REVENUE
Revenue $71.60M $12.80M $17.93M
Cost of Revenue $88.69M $5.95M $8.41M
Gross Profit $-17.09M $6.85M $9.51M
OPERATING EXPENSES
R&D Expense - $3.03M $3.87M
SG&A Expense $19.81M $9.99M $8.79M
Other Operating Expenses (derived) - $7.15M $7.31M
Operating Income $-37.50M $-13.33M $-10.46M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-8.00K $-26.00K $-1.00K
Pretax Income $-49.30M $-11.70M $-11.33M
Income Tax $0 $0 -
Net Income $-50.32M $-11.70M $-11.33M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.36 $-4.91 $-8.43
Diluted Shares 138.70M - 20.16M
EBITDA $22.84M $-11.75M $-8.85M
Depreciation & Amortization $60.34M $1.57M $1.61M
Balance Sheet
ASSETS
Cash & Equivalents $9.66M $1.17M $4.49M
Accounts Receivable $12.54M $7.31M $7.24M
Inventory - $4.82M $4.57M
Other Current Assets $2.20M $750.00K $541.00K
Current Assets $44.25M $14.05M $18.84M
PP&E (Net) $32.08M $1.29M $1.58M
Goodwill $54.51M $431.00K $431.00K
Intangible Assets - $3.50M $4.58M
Other Noncurrent Assets $520.00K $311.00K $433.00K
Noncurrent Assets $281.63M $6.06M $7.81M
Total Assets $325.87M $20.11M $26.65M
LIABILITIES
Accounts Payable $9.05M $1.43M $1.55M
Short-term Debt $3.37M - -
Other Current Liabilities (derived) $74.47M $218.00K $194.00K
Current Liabilities $86.89M $8.64M $7.54M
Long-term Debt $474.00K - -
Other Noncurrent Liabilities (derived) $56.47M $89.00K $181.00K
Noncurrent Liabilities $56.95M $2.45M $6.41M
Total Liabilities $143.84M $11.08M $13.95M
EQUITY
Common Stock $145.00K $37.00K $22.00K
Additional Paid-in Capital $379.34M $272.08M $262.20M
Retained Earnings $-199.46M $-262.40M $-250.48M
Accumulated OCI - $-692.00K $957.00K
Total Equity $180.03M $9.03M $12.71M
Temporary Equity $2.01M - -
Total Liabilities & Equity $325.87M $20.11M $26.65M
SUPPLEMENTAL
Total Debt $3.84M - -
Shares Outstanding 145.21M 3.56M 1.48M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $39.07M $-11.80M $-9.85M
Capital Expenditures $26.88M $188.00K $37.00K
Cash from Investing $-25.17M $-188.00K $-37.00K
Cash from Financing $-6.63M $6.63M $7.77M
Free Cash Flow $12.19M $-11.99M $-9.88M
Beginning Cash (CFS) $2.40M $6.49M $8.64M
Net Change in Cash $7.27M $-5.36M $-2.11M
Effect of FX on Cash $0 $36.00K $-31.00K
Calculated Ending Cash $9.66M $1.17M $6.49M
Cash per BS $9.66M $1.17M $4.49M
Cash scope difference (CFS − BS) - - $2.00M
Cash per CFS $9.66M $1.17M $6.49M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ChronoScale Holdings Corp's annual revenue?

ChronoScale Holdings Corp reported $11.57M in revenue for trailing twelve months (ending March 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ChronoScale Holdings Corp profitable?

No. ChronoScale Holdings Corp reported $-15.69M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does ChronoScale Holdings Corp generate free cash flow?

No. Free cash flow was $-12.14M for trailing twelve months. Operating cash flow was $-11.96M.